Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

Treatment of insulin resistance through inhibitors of transcription factor TSC22D4

US Patent 9879258 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Cell contacting arrangement for an energy storage module2024
Battery, carrier board, and carrier board element having locking elements2021
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2021
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2021
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2020
Oligonucleotide sequences targeting transcription factor TSC22D4 for the treatme2020
Cell contact-making system, cell module and method for producing a cell module2020
MicroRNAs modulating the effect of glucocorticoid signaling2018
MicroRNAs modulating the effect of glucocorticoid signaling2018
Protein kinase B/Akt modulators and methods for the use thereof2007
Methods for indentifying compounds that modulate gluconeogenesis through the bin2005